A detailed history of Marathon Asset Management LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Marathon Asset Management LTD holds 762,151 shares of RPRX stock, worth $19.6 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
762,151
Previous 743,727 2.48%
Holding current value
$19.6 Million
Previous $19.6 Million 9.94%
% of portfolio
0.74%
Previous 0.65%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$25.63 - $29.27 $472,207 - $539,270
18,424 Added 2.48%
762,151 $21.6 Million
Q2 2024

Aug 14, 2024

SELL
$26.26 - $29.9 $1.28 Million - $1.46 Million
-48,680 Reduced 6.14%
743,727 $19.6 Million
Q1 2024

May 14, 2024

SELL
$27.46 - $31.33 $1.65 Million - $1.88 Million
-60,011 Reduced 7.04%
792,407 $24.1 Million
Q4 2023

Feb 12, 2024

BUY
$26.21 - $29.22 $2.27 Million - $2.53 Million
86,585 Added 11.31%
852,418 $23.9 Million
Q3 2023

Nov 06, 2023

SELL
$26.26 - $31.38 $980,390 - $1.17 Million
-37,334 Reduced 4.65%
765,833 $20.8 Million
Q2 2023

Aug 04, 2023

SELL
$29.6 - $36.56 $2.66 Million - $3.29 Million
-90,025 Reduced 10.08%
803,167 $24.7 Million
Q1 2023

May 03, 2023

SELL
$32.77 - $39.4 $4.52 Million - $5.44 Million
-138,077 Reduced 13.39%
893,192 $32.2 Million
Q4 2022

Feb 07, 2023

SELL
$39.17 - $44.04 $1.66 Million - $1.87 Million
-42,476 Reduced 3.96%
1,031,269 $40.8 Million
Q3 2022

Oct 25, 2022

SELL
$39.88 - $44.65 $35.6 Million - $39.8 Million
-891,591 Reduced 45.37%
1,073,745 $43.1 Million
Q2 2022

Aug 01, 2022

SELL
$37.53 - $44.22 $4.18 Million - $4.93 Million
-111,392 Reduced 5.36%
1,965,336 $82.6 Million
Q1 2022

Apr 21, 2022

SELL
$37.46 - $42.44 $6.2 Million - $7.03 Million
-165,602 Reduced 7.39%
2,076,728 $80.9 Million
Q4 2021

Jan 28, 2022

BUY
$35.17 - $42.48 $78.9 Million - $95.3 Million
2,242,330 New
2,242,330 $89.4 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Marathon Asset Management LTD Portfolio

Follow Marathon Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Asset Management LTD with notifications on news.